OR WAIT null SECS
August 15, 2019
The latest research from GlobalData has revealed that more than two-thirds (69%) of CMOs high-containment facilities are based in the top five European Union countries and Switzerland.
Nephron Pharmaceuticals is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing.
August 14, 2019
The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.
August 13, 2019
Using Alternating Tangential Flow in a 3000-L perfusion bioreactor, the company expects to reduce production time by up to 30%
August 08, 2019
The company has launched new services for mammalian cell bank manufacturing under GMP conditions.
August 07, 2019
An affiliate of the Permira funds has signed an agreement to purchase Cambrex in an approximately $2.4-billion transaction.
August 02, 2019
As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.
Pharmaceutical Technology Europe celebrates 30 years in publishing the latest insights, analysis, and developments of the bio/pharma industry.
The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.
To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.